CSF3 and anemia (phenotype): In contrast, median RAM RDI was 93.3% and 89.5% in baseline anemia, which was not significant (P = 0.18), although a significant difference was identified in prophylactic G-CSF use (95.8% vs. 83.4%, respectively, P = 0.002).